Status:
COMPLETED
Echocardiography-guided Percutaneous Patent Ductus Arteriosus Closure
Lead Sponsor:
National Cardiovascular Center Harapan Kita Hospital Indonesia
Conditions:
Echocardiography
PDA
Eligibility:
All Genders
Up to 18 years
Brief Summary
Since the first successful percutaneous closure under transoesophageal echocardiographic (TEE) guidance, many centres explored transcatheter procedures without fluoroscopy. This single centre study ai...
Detailed Description
From March 2019 to April 2020, a total of 60 patients with PDA were recruited as participants for this prospective, single-centre, non-randomized clinical trial. They were divided equally into two gro...
Eligibility Criteria
Inclusion
- PDA, age \<= 18yo
Exclusion
- \>= 18yo, Eisenmenger syndrome, coexistence of other associated congenital heart disease
Key Trial Info
Start Date :
March 12 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 23 2020
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05321849
Start Date
March 12 2019
End Date
June 23 2020
Last Update
April 11 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cardiovascular Center Harapan Kita Jakarta Indonesia
Jakarta, Indonesia, 11420